Sponsor Pipeline

Dyne Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
2
Phase 3
1
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT07486934
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants…		 Trial sites expanded: 25 -> 33 locations
2026-08-12 NCT05524883
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in…		 date change Primary completion pushed: 2029-11 -> 2031-09
2026-08-12 NCT05524883
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in…		 date change Completion pushed: 2029-11 -> 2031-09
2026-07-31 NCT07486934
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants…		 Trial sites expanded: 21 -> 24 locations
Active Trials by Phase
Phase 3
2
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07608432 Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered… Duchenne Muscular Dystrophy (DMD) Recruiting
NCT07486934 Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants… Myotonic Dystrophy Type 1 (DM1) Recruiting
Phase 1/2
NCT05481879 Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in… Myotonic Dystrophy Type 1 (DM1) Recruiting
NCT05524883 Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in… Duchenne Muscular Dystrophy (DMD) Active, Not Recruiting
Disease Areas
Duchenne Muscular Dystrophy (2)
Get alerts when Dyne Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free